BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16014605)

  • 1. Beta-catenin, cancer, and G proteins: not just for frizzleds anymore.
    Malbon CC
    Sci STKE; 2005 Jul; 2005(292):pe35. PubMed ID: 16014605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.
    Yang M; Zhong WW; Srivastava N; Slavin A; Yang J; Hoey T; An S
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6027-32. PubMed ID: 15837931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
    Hernández M; Barrero MJ; Crespo MS; Nieto ML
    J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases.
    Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J
    Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells.
    Guo L; He P; No YR; Yun CC
    Cell Signal; 2015 May; 27(5):961-8. PubMed ID: 25683913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.
    Leve F; Peres-Moreira RJ; Binato R; Abdelhay E; Morgado-Díaz JA
    PLoS One; 2015; 10(9):e0139094. PubMed ID: 26418031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid activates β-catenin/T cell factor signaling, which contributes to the suppression of apoptosis in H19-7 cells.
    Sun Y; Kim NH; Ji L; Kim SH; Lee J; Rhee HJ
    Mol Med Rep; 2013 Dec; 8(6):1729-33. PubMed ID: 24145616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5.
    Zhang H; Bialkowska A; Rusovici R; Chanchevalap S; Shim H; Katz JP; Yang VW; Yun CC
    J Biol Chem; 2007 May; 282(21):15541-9. PubMed ID: 17430902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
    Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
    Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
    Lee SJ; Ritter SL; Zhang H; Shim H; Hall RA; Yun CC
    Gastroenterology; 2011 Mar; 140(3):924-34. PubMed ID: 21134377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
    Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
    Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
    Burkhalter RJ; Westfall SD; Liu Y; Stack MS
    J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lysophosphatidic acid in the physiology and pathology of the skin.
    Lei L; Su J; Chen J; Chen W; Chen X; Peng C
    Life Sci; 2019 Mar; 220():194-200. PubMed ID: 30584899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
    Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
    Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of Frizzleds.
    Wang HY; Liu T; Malbon CC
    Cell Signal; 2006 Jul; 18(7):934-41. PubMed ID: 16480852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
    Hurst JH; Henkel PA; Brown AL; Hooks SB
    Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of lysophosphatidic acid in cancer.
    Mills GB; Moolenaar WH
    Nat Rev Cancer; 2003 Aug; 3(8):582-91. PubMed ID: 12894246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid modulates the association of PTP1B with N-cadherin/catenin complex in SKOV3 ovarian cancer cells.
    Huang RY; Wen CC; Liao CK; Wang SH; Chou LY; Wu JC
    Cell Biol Int; 2012 Sep; 36(9):833-41. PubMed ID: 22582758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of early gene induction and cell proliferation by lysophosphatidic acid in human amnion-derived WISH cells: role of phospholipase D-mediated pathway.
    Kim JI; Jo EJ; Lee HY; Kang HK; Lee YN; Kwak JY; Bae YS
    Biochem Pharmacol; 2004 Jul; 68(2):333-40. PubMed ID: 15194005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.